Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine

Carcinogenesis

Volumn 23, Issue 6, 2002, Pages 993-1001

  Seril, Darren N ^a   Liao, Jie ^a   Ho, Kwok Lam K ^a   Yang, Chung S ^a   Yang, Guang Yu ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACETYLCYSTEINE; ANTIOXIDANT; DEXTRAN SULFATE; IRON; NITRIC OXIDE SYNTHASE; PARACETAMOL;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SIZE; CELL DAMAGE; CELL PROLIFERATION; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIET; DRUG MECHANISM; FEMALE; FLUID INTAKE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MOUSE; MOUSE STRAIN; NITROSATION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STRESS; ULCERATIVE COLITIS;

EID: 0036313896     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.6.993     Document Type: Article

References (58)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Cancer, dysplasia and surveillance in patients with ulcerative colitis. A critical review
3. Ulcerative colitis and colorectal cancer. A population-based study
4. Cancer morbidity in ulcerative colitis
5. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis
6. Molecular mechanism for inflammation-promoted pathogenesis of cancer-the sixteenth international symposium of the Sapporo cancer seminar
7. Oxidants and free radicals in inflammatory bowel disease
8. Depleted mucosal antioxidant defenses in inflammatory bowel disease
9. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease
10. Nitric oxide in ulcerative colitis
11. Serum nitrate levels in ulcerative colitis and Crohn's disease
12. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease
13. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
14. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease
15. Oxygen radicals in ulcerative colitis
16. Interaction of reactive oxygen species with DNA. A Review
17. The multifacted roles of nitric oxide in cancer
18. Role of oxidative DNA damage in cancer initiation and promotion
19. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
20. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes
21. N-acetylcysteine: Pharmacological considerations and experimental and clinical applications
22. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points
23. Inhibition of urethane-induced, lung tumors in mice by dietary N-acetylcysteine
24. Anticarcinogenesis mechanism, as evaluated in the multistage mouse skin model
25. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon
26. Chemoprevention of colon carcinogenesis by organosulfur compounds
27. Replenishment of glutathione levels improves mucosal function in experimental acute colitis
28. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10 (-/-) mice
29. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, β-catenin and p53 expression and the role of inflammation
30. Interleukin-10-deficient mice and inflammatory bowel disease associated cancer development
31. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
32. Histochemical study of colonic cancer in experimental colitis of rats
33. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulfate sodium
34. Oral or parenteral iron treatment in chronic ulcerative colitis?
35. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice
36. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
37. Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice
38. Biological response to phorbol ester determined by alternative G1 pathways
39. Effects of thiols on topoisomerase-IIα activity and cell cycle progression
40. Induction of cyclin-dependent kinase inhibitors and G1 prolongation by the chemopreventive agent N-acetylcysteine
41. N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps
42. Notes from some crypt watchers: Regulation of renewal in the mouse intestinal epithelium
43. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics
44. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells
45. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts
46. Nitrosation and oxidation in the regulation of gene expression
47. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
48. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulfate sodium (DSS)-induced colitis
49. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates
50. Inflammation and cancer: Back to Virchow?
51. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair
52. Clinical development plan: N-Acetyl-1-cysteine
53. Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background
54. Smokers and urinary genotoxins: Implications for selection of cohorts and modulation of endpoints in chemoprevention trials
55. Chemoprevention of colorectal tumors: Role of lactulose and of other agents
56. Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats
57. Chemoprevention by N-acetylcysteine of urethane-induced clastogenicity and lung tumors in mice
58. Nutrient density: An important and useful tool for laboratory animal studies